Effect of long-term nitrate treatment on cardiac events in patients with vasospastic Angina

Circulation Journal

Volumn 75, Issue 9, 2011, Pages 2196-2205

  Kosugi, Munenori ^a   Nakagomi, Akihiro ^a   Shibui, Toshiyuki ^a   Kato, Katsuhito ^a   Kusama, Yoshiki ^a   Atarashi, Hirotsugu ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Nitrate; Tolerance; Vasospastic angina

Indexed keywords

ACETYLCHOLINE; AMLODIPINE; BENIDIPINE; DILTIAZEM; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; MANIDIPINE; NIFEDIPINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR EFFECT; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SPASM; DRUG EFFECT; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEART VENTRICULOGRAPHY; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; PROVOCATION TEST; RECEIVER OPERATING CHARACTERISTIC; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS; VASOSPASTIC ANGINA;

ACUTE CORONARY SYNDROME; AGED; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NICORANDIL; NITRATES; PROSPECTIVE STUDIES;

EID: 80052160963     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0056     Document Type: Article

References (31)

1. JCS Joint Working Group. Guideline for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): Digest version. Circ J 2010; 74: 1745-1762.
2. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med 1998; 338: 520-531.
3. Daiber A, Wenzel P, Oelze M, Münzel T. New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin Res Cardiol 2008; 97: 12-20.
4. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm-clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 2008; 51: 2-17.
5. Ito A, Fukumoto Y, Shimokawa H. Changing characteristics associated with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol 2004; 44: 480-485.
6. Yamagishi M, Ito K, Tsutsui H, Miyazaki S, Goto Y, Nagaya N, et al. Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonist. Circ J 2003; 67: 1029-1035.
7. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13: 621-630.
8. Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation 2000; 102: 118-122.
9. Curfman GD, Heinsimer JA, Lozner EC, Fung HL. Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: A prospective, randomized trial. Circulation 1983; 67: 276-282.
10. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey Jr DEC, et al. ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction). Circulation 2007; 116: e148-e304.
11. GISS (Gruppo Italiano per lo studio della Sopravvivenza nell' Infarto Miocardioco)-3. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial. Lancet 1994; 343: 1115-1122.
12. ISIS-4 (Fourth International Study of Infarct Survival). A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-685.
13. Nagao K, Kanmatsuse K, Ooiwa K, Satou K, Watanabe I, Yamashita M, et al. The effects of long-acting nitrates on 5-year cardiac events of patients with coronary thrombotic therapy for acute myocardial infarction. Intern Med 2000; 39: 877-884.
14. Ishikawa K, Kanamasa K, Ogawa I, Takenaka T, Naito T, Kamata N, et al. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Jpn Circ J 1996; 60: 779-788.
15. Itoh T, Mizuno Y, Harada E, Yoshimura M, Ogawa H, Yasue H. Coronary spasm is associated with chronic low-grade inflammation. Circ J 2007; 71: 1074-1078.
16. Suzuki M, Nishizaki M, Arita M, Kakuta T, Numano F. Impaired glucose tolerance with late hypersecretion of insulin during oral glucose tolerance test in patients with vasospastic angina. J Am Coll Cardiol 1996; 27: 1458-1463.
17. Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Hara Y, Tsushima M, et al. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 1995; 92: 1749-1757.
18. Yoo SY, Kim JY. Recent insights into the mechanisms of vasospastic angina. Korean Circ J 2009; 39: 505-511.
19. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: Lessons from animal models. Circ J 2000; 64: 1-12.
20. Yamamoto T, Kajikuri J, Watanabe Y, Suzuki Y, Suzumori K, Itoh T. Chronic nitroglycerin administration reduces endothelial nitric oxide production in rabbit mesenteric resistance artery. Br J Pharmocol 2005; 146: 534-542.
21. Thomas GR, DiFabio JM, Gori T, Parker JD. Once daily therapy with isosornide-5-mononitrate causes endothelial dysfunction in humans. J Am Coll Cardiol 2007; 49: 1289-1295.
22. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1-9.
23. Saito S, Yamagishi M, Takayama T, Chiku M, Koyama J, Ito K, et al. Plaque morphology at coronary sites with focal spasm in variant angina: Study using intravascular ultrasound. Circ J 2003; 67: 1041-1045.
24. Wakabayashi K, Suzuki H, Honda Y, Wakatsuki D, Kawachi K, Ota K, et al. Provoked coronary spasm predicts adverse outcome in patients with acute myocardial infarction: A novel predictor of prognosis after acute myocardial infarction. J Am Coll Cardiol 2008; 52: 518-522.
25. Ozaki Y, Keane D, Serruys PW. Progression and regression of coronary stenosis in the long-term follow-up of vasospastic angina. Circulation 1995; 92: 2446-2456.
26. Hirai N, Kawano H, Yasue H, Shimomura H, Miyamoto S, Soejima H, et al. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina. Circulation 2003; 108: 1446-1450.
27. Zhou Q, Liao JK. Pleiotropic effects of statins: Basic research and clinical perspectives. Circ J 2010; 74: 818-826.
28. Miyauchi K, Daida H. Clinical significance of intensive lipid-lowering therapy using statins in patients with coronary artery disease: LDL-cholesterol: The lower, the better; Is it true for Asians? (Pro) Circ J 2010; 74: 1718-1730.
29. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 2008; 51: 1742-1748.
30. Ferratini M, Merlini PP, Silva P, Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: A comparison with a continuous schedule. Eur Heart J 1989; 10: 998-1002.
31. Ahlner AJ, Anderson RG, Torfgard K, Axelsson KL. Organic nitrate esters: Clinical use and mechanisms of actions. Pharmacol Rev 1991; 43: 351-423.